[HTML][HTML] Renal effects of GLP-1 receptor agonists and tirzepatide in individuals with type 2 diabetes: seeds of a promising future
I Caruso, F Giorgino - Endocrine, 2024 - Springer
Purpose Chronic kidney disease (CKD) is one of the most common complications of type 2
diabetes (T2D), and CKD-related disability and mortality are increasing despite the recent …
diabetes (T2D), and CKD-related disability and mortality are increasing despite the recent …
Renal effects of GLP-1 receptor agonists and tirzepatide in individuals with type 2 diabetes: seeds of a promising future
I Caruso, F Giorgino - Endocrine - pubmed.ncbi.nlm.nih.gov
Purpose Chronic kidney disease (CKD) is one of the most common complications of type 2
diabetes (T2D), and CKD-related disability and mortality are increasing despite the recent …
diabetes (T2D), and CKD-related disability and mortality are increasing despite the recent …
Renal effects of GLP-1 receptor agonists and tirzepatide in individuals with type 2 diabetes: seeds of a promising future.
I Caruso, F Giorgino - Endocrine, 2024 - europepmc.org
Purpose Chronic kidney disease (CKD) is one of the most common complications of type 2
diabetes (T2D), and CKD-related disability and mortality are increasing despite the recent …
diabetes (T2D), and CKD-related disability and mortality are increasing despite the recent …